Celularity Inc. (CELU) vs Dogwood Therapeutics, Inc. (DWTX)
A side-by-side comparison of Celularity Inc. and Dogwood Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.70HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
DWTX
Dogwood Therapeutics, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — CELU vs DWTX
growth of $100 · dividends reinvested · last 6yCELU -98.5% (-50.2%/yr)DWTX -99.6% (-60.8%/yr)CELU compounded faster over this window
CELU DWTX
CELU vs DWTX: by the numbers
- •DWTX is the larger company ($53M vs $49M market cap).
- •Both run net losses; DWTX's is the smaller (0.00% vs -375.77% net margin).
Metrics side by side
Valuation
| Metric | CELU | DWTX |
|---|---|---|
| P/S ratio | 2.59 | N/A |
| P/B ratio | N/A | 0.77 |
Profitability
| Metric | CELU | DWTX |
|---|---|---|
| Gross margin | 79.62% | 0.00% |
| Operating margin | -230.92% | 0.00% |
| Net margin | -375.77% | 0.00% |
| ROE | N/A | -52.72% |
| ROIC | -192.99% | -38.04% |
Growth (annualized)
| Metric | CELU | DWTX |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -58.44% |
Frequently asked
- How have CELU and DWTX total returns compared?
- Over the past 5 years, CELU delivered -52.57% and DWTX delivered -58.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.